No Reduction of ST-segment Elevation Myocardial Infarction Admission in Taiwan During Coronavirus Pandemic.
作者信息
Li Yi-Heng, Huang Wei-Chun, Hwang Juey-Jen
机构信息
Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan.
Department of Critical Care Medicine, Kaohsiung Veterans General Hospital, Kaohsiung, Taiwan; School of Medicine, National Yang-Ming University, Taipei, Taiwan; Department of Physical Therapy, Fooyin University, Kaohsiung, Taiwan.
出版信息
Am J Cardiol. 2020 Sep 15;131:133-134. doi: 10.1016/j.amjcard.2020.06.030. Epub 2020 Jun 27.
Abstract
摘要
相似文献
1
No Reduction of ST-segment Elevation Myocardial Infarction Admission in Taiwan During Coronavirus Pandemic.台湾地区新冠疫情期间ST段抬高型心肌梗死入院率未降低。
Am J Cardiol. 2020 Sep 15;131:133-134. doi: 10.1016/j.amjcard.2020.06.030. Epub 2020 Jun 27.
2
Effect of the COVID-19 Pandemic on ST-Segment-Elevation Myocardial Infarction Presentations and In-Hospital Outcomes.2019年冠状病毒病大流行对ST段抬高型心肌梗死表现及院内结局的影响
Circ Cardiovasc Interv. 2020 Jul;13(7):e009438. doi: 10.1161/CIRCINTERVENTIONS.120.009438.
3
ST-Segment-Elevation Myocardial Infarction Care and COVID-19: The Value Proposition of Fibrinolytic Therapy and the Pharmacoinvasive Strategy.ST段抬高型心肌梗死的治疗与COVID-19：溶栓治疗和药物介入策略的价值主张
Circ Cardiovasc Qual Outcomes. 2020 Jun;13(6):e006834. doi: 10.1161/CIRCOUTCOMES.120.006834. Epub 2020 Apr 27.
4
Why Fibrinolytic Therapy for ST-Segment-Elevation Myocardial Infarction in the COVID-19 Pandemic Is Not Your New Best Friend.为何在新冠疫情期间，ST段抬高型心肌梗死的纤溶治疗并非你新的最佳选择。
Circ Cardiovasc Qual Outcomes. 2020 Jun;13(6):e006885. doi: 10.1161/CIRCOUTCOMES.120.006885. Epub 2020 Apr 27.
5
Reperfusion of ST-Segment-Elevation Myocardial Infarction in the COVID-19 Era: Business as Usual?新冠疫情时代ST段抬高型心肌梗死的再灌注治疗：一切照旧？
Circulation. 2020 Jun 16;141(24):1948-1950. doi: 10.1161/CIRCULATIONAHA.120.047122. Epub 2020 Apr 13.
6
Assessment of ST-Segment Elevation Myocardial Infarction Volume Trends During The COVID-19 Pandemic.新冠疫情期间ST段抬高型心肌梗死体积趋势评估
Am J Cardiol. 2020 Sep 15;131:132-133. doi: 10.1016/j.amjcard.2020.06.029. Epub 2020 Jun 27.
7
Primary Percutaneous Coronary Intervention or Fibrinolytic Therapy in COVID 19 Patients Presenting With ST-Segment Elevation Myocardial Infarction.新冠病毒 19 型合并 ST 段抬高型心肌梗死患者的直接经皮冠状动脉介入治疗或溶栓治疗
Am J Cardiol. 2020 Nov 1;134:158. doi: 10.1016/j.amjcard.2020.08.021. Epub 2020 Aug 22.
8
Treatment of ST-Segment Elevation Myocardial Infarction During COVID-19 Pandemic.2019冠状病毒病大流行期间ST段抬高型心肌梗死的治疗
Cardiovasc Revasc Med. 2020 Aug;21(8):1024-1029. doi: 10.1016/j.carrev.2020.05.027. Epub 2020 May 21.
9
Trends and Outcomes of Fibrinolytic Therapy for STEMI: Insights and Reflections in the COVID-19 Era.ST段抬高型心肌梗死的纤维蛋白溶解疗法的趋势与结果：COVID-19时代的见解与思考
JACC Cardiovasc Interv. 2020 Oct 12;13(19):2312-2314. doi: 10.1016/j.jcin.2020.07.004.
10
Comparison of Clinical Outcomes in Patients with ST Elevation Myocardial Infarction with Percutaneous Coronary Intervention and the Use of a Telemedicine App Before and After the COVID-19 Pandemic at a Center in Beijing, China, from August 2019 to March 2020.比较 2019 年 8 月至 2020 年 3 月在中国北京一家中心的 COVID-19 大流行前后行经皮冠状动脉介入治疗和使用远程医疗应用的 ST 段抬高型心肌梗死患者的临床结局。
Med Sci Monit. 2020 Sep 17;26:e927061. doi: 10.12659/MSM.927061.
引用本文的文献
1
Assessment of cardiac dysfunction in COVID-19 patients using layer-specific strain echocardiography in short-axis and long-axis views.使用短轴和长轴视图的分层应变超声心动图评估COVID-19患者的心脏功能障碍。
BMC Cardiovasc Disord. 2025 Aug 13;25(1):602. doi: 10.1186/s12872-025-04971-7.
2
Impact of the Coronavirus Disease 2019 Pandemic on the Management and Outcomes of ST-Segment Elevation Myocardial Infarction Patients: A Retrospective Cohort Study.2019冠状病毒病大流行对ST段抬高型心肌梗死患者管理及结局的影响：一项回顾性队列研究
Medicina (Kaunas). 2025 Feb 27;61(3):422. doi: 10.3390/medicina61030422.
3
Impact of the COVID-19 Pandemic on Door-to-Device Time Segments and Clinical Outcomes for STEMI Patients in Northern Taiwan.2019冠状病毒病大流行对台湾北部ST段抬高型心肌梗死患者门到器械时间及临床结局的影响
Acta Cardiol Sin. 2025 Jan;41(1):121-129. doi: 10.6515/ACS.202501_41(1).20241021A.
4
Impact of the Integrated Activation System on Door-to-Balloon Times and Clinical Outcomes in STEMI Patients Receiving Primary PCI.综合激活系统对接受直接经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者门球时间及临床结局的影响
Acta Cardiol Sin. 2024 Jan;40(1):97-110. doi: 10.6515/ACS.202401_40(1).20230619D.
5
The impact of COVID-19 epidemic on emergency department visits of older patients in Taiwan.COVID-19 疫情对台湾老年患者急诊科就诊的影响。
BMC Geriatr. 2023 Aug 14;23(1):490. doi: 10.1186/s12877-023-04164-x.
6
Non-COVID outcomes associated with the coronavirus disease-2019 (COVID-19) pandemic effects study (COPES): A systematic review and meta-analysis.与 2019 年冠状病毒病（COVID-19）大流行影响研究（COPES）相关的非 COVID 结局：系统评价和荟萃分析。
PLoS One. 2022 Jun 24;17(6):e0269871. doi: 10.1371/journal.pone.0269871. eCollection 2022.
7
Global burden of the COVID-19 associated patient-related delay in emergency healthcare: a panel of systematic review and meta-analyses.全球 COVID-19 相关的急诊医疗患者相关延误负担：一组系统评价和荟萃分析。
Global Health. 2022 Jun 8;18(1):58. doi: 10.1186/s12992-022-00836-2.
8
Impact of SARS-CoV-2 Outbreak on Emergency Department Presentation and Prognosis of Patients with Acute Myocardial Infarction: A Systematic Review and Updated Meta-Analysis.2019冠状病毒病疫情对急性心肌梗死患者急诊科就诊情况及预后的影响：一项系统评价与更新的荟萃分析
J Clin Med. 2022 Apr 21;11(9):2323. doi: 10.3390/jcm11092323.
9
Impact of the first COVID-19 wave on quality of care in acute coronary syndrome - the importance of information for health policy design.新冠疫情第一波对急性冠状动脉综合征医疗质量的影响——信息对卫生政策设计的重要性
Rev Port Cardiol. 2022 Mar;41(3):229-230. doi: 10.1016/j.repc.2022.01.001. Epub 2022 Jan 13.
10
Stent-Save a Life international survey on the practice of primary percutaneous coronary intervention during the COVID-19 pandemic.“支架拯救生命”国际组织关于2019冠状病毒病大流行期间直接经皮冠状动脉介入治疗实践的调查。
Rev Port Cardiol. 2022 Mar;41(3):221-227. doi: 10.1016/j.repc.2021.04.006. Epub 2021 Dec 25.
本文引用的文献
1
The Covid-19 Pandemic and the Incidence of Acute Myocardial Infarction.新冠疫情与急性心肌梗死的发病率
N Engl J Med. 2020 Aug 13;383(7):691-693. doi: 10.1056/NEJMc2015630. Epub 2020 May 19.
2
Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era.意大利 COVID-19 时代心肌梗死住院人数减少。
Eur Heart J. 2020 Jun 7;41(22):2083-2088. doi: 10.1093/eurheartj/ehaa409.
3
Impact of Coronavirus Disease 2019 (COVID-19) Outbreak on ST-Segment-Elevation Myocardial Infarction Care in Hong Kong, China.2019年冠状病毒病（COVID-19）疫情对中国香港ST段抬高型心肌梗死治疗的影响
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631. doi: 10.1161/CIRCOUTCOMES.120.006631. Epub 2020 Mar 17.
4
Response to COVID-19 in Taiwan: Big Data Analytics, New Technology, and Proactive Testing.台湾对COVID-19的应对：大数据分析、新技术与主动检测
JAMA. 2020 Apr 14;323(14):1341-1342. doi: 10.1001/jama.2020.3151.
5
The Taiwan Heart Registries: Its Influence on Cardiovascular Patient Care.《台湾心脏注册研究：对心血管病患者治疗的影响》。
J Am Coll Cardiol. 2018 Mar 20;71(11):1273-1283. doi: 10.1016/j.jacc.2018.02.006.
Zotero 插件